✦ LIBER ✦

Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin

✍ Scribed by Han Ying Bao; Wei Jia Fang; Xiao Chen Zhang; Gen Ming Shi; Sui Huang; Lan Fang Yu; Jin Chen; Hai Bo Mou; Jing Deng; Peng Shen; Nong Xu

Publisher: Springer
Year: 2010
Tongue: English
Weight: 269 KB
Volume: 67
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1301-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of biweekly irinotecan an

Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer

✍ Yasuhide Yamada; Kuniaki Shirao; Ichinosuke Hyodo; Yasuaki Arai; Tadamichi Denda 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 190 KB

Suramin in patients with metastatic colo

Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II Study

✍ Alfredo Falcone; Elisabetta Pfanner; Claudia Cianci; Romano Danesi; Isa Brunetti 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB 👁 2 views

Phase II study of tallysomycin S10b in p

Phase II study of tallysomycin S10b in patients with advanced colorectal cancer

✍ C. Nicaise; J. Ajani; P. Goudeau; M. Rozencweig; B. Levin; I. Krakoff 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 201 KB

Chronomodulated administration of oxalip

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

✍ Daniele Santini; Bruno Vincenzi; Gaia Schiavon; Marisa Di Seri; Vladimir Virzí; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB

Phase II study of oxaliplatin in patient

Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma

✍ Yasuhiro Oki; Peter McLaughlin; Barbara Pro; Fredrick B. Hagemeister; Archie Ble 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

A phase I/II trial of docetaxel and oxal

A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer

✍ Kyoung Ha Kim; Young Suk Park; Myung Hee Chang; Hyo Song Kim; Hyun Jung Jun; Jie 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 274 KB